Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Helicobacter pylori infection causes both protective and deleterious effects in human health and disease

Abstract

Infection with Helicobacter pylori (H. pylori) is necessary but not sufficient for the development of gastric cancer, the third leading cause of cancer death globally. H. pylori infection affects over half of people globally; however, it does not affect populations uniformly. H. pylori infection rates are declining in western industrialized countries but are plateauing in developing and newly industrialized countries where gastric cancer is most prevalent. Despite H. pylori infection being the primary causative agent for gastric cancer, H. pylori infection can also cause other effects, detrimental or beneficial, throughout an individual’s life, with the beneficial effects often being seen in childhood and the deleterious effects in adulthood. H. pylori is an ancient bacterium and its likelihood of affecting disease or health is dependent on both human and bacterial genetics that have co-evolved over millennia. In this review, we focus on the impact of infection and its genetic bases in different populations and diseases throughout an individual’s lifespan, highlighting the benefits of individualized treatment and argue that universal eradication of H. pylori in its host may cause more harm than good for those infected with H. pylori.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Global distribution of H. pylori and gastric cancer.
Fig. 2: H. pylori colonization.

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Correa P, Piazuelo MB. Helicobacter pylori infection and gastric adenocarcinoma. US Gastroenterol Hepatol Rev. 2011;7:59–64.

    PubMed  PubMed Central  Google Scholar 

  4. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015;148:719–31.

    Article  PubMed  Google Scholar 

  5. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420–9.

    Article  PubMed  Google Scholar 

  6. den Hollander WJ, Holster IL, den Hoed CM, van Deurzen F, van Vuuren AJ, Jaddoe VW, et al. Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol. 2013;28:1705–11.

    Article  Google Scholar 

  7. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003;106:953–60.

    Article  CAS  PubMed  Google Scholar 

  8. Tavera G, Morgan DR, Williams SM. Tipping the scale toward gastric disease: a host-pathogen genomic mismatch? Curr Genet Med Rep. 2018;6:199–207.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.

    Article  Google Scholar 

  10. Correa P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomark Prev. 1996;5:477–81.

    CAS  Google Scholar 

  11. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, Kunstmann E, et al. Free recombination within Helicobacter pylori. Proc Natl Acad Sci USA. 1998;95:12619–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39:14–23.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863–73.

    Article  CAS  PubMed  Google Scholar 

  14. Wroblewski LE, Peek RM Jr., Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23:713–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Maixner F, Krause-Kyora B, Turaev D, Herbig A, Hoopmann MR, Hallows JL, et al. The 5300-year-old Helicobacter pylori genome of the Iceman. Science. 2016;351:162–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, et al. Age of the association between Helicobacter pylori and man. PLoS Pathog. 2012;8:e1002693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, et al. Traces of human migrations in Helicobacter pylori populations. Science. 2003;299:1582–5.

    Article  CAS  PubMed  Google Scholar 

  18. Vale FF, Vadivelu J, Oleastro M, Breurec S, Engstrand L, Perets TT, et al. Dormant phages of Helicobacter pylori reveal distinct populations in Europe. Sci Rep. 2015;5:14333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Burkitt MD, Duckworth CA, Williams JM, Pritchard DM. Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models. Dis Model Mech. 2017;10:89–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ciesielski TH, Pendergrass SA, White MJ, Kodaman N, Sobota RS, Huang M, et al. Diverse convergent evidence in the genetic analysis of complex disease: coordinating omic, informatic, and experimental evidence to better identify and validate risk factors. BioData Min. 2014;7:10.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Maixner F, Thorell K, Granehall L, Linz B, Moodley Y, Rattei T, et al. Helicobacter pylori in ancient human remains. World J Gastroenterol. 2019;25:6289–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, Francois F, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006;103:732–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Borbet TC, Zhang X, Muller A, Blaser MJ. The role of the changing human microbiome in the asthma pandemic. J Allergy Clin Immunol. 2019;144:1457–66.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut. 2008;57:561–7.

    Article  PubMed  Google Scholar 

  25. Blaser MJ. Equilibria of humans and our indigenous microbiota affecting asthma. Proc Am Thorac Soc. 2012;9:69–71.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799–809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111–5.

    CAS  PubMed  Google Scholar 

  28. Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer. Toxins (Basel). 2018;10:163.

    Article  CAS  Google Scholar 

  29. Thorell K, Lehours P, Vale FF. Genomics of Helicobacter pylori. Helicobacter. 2017;22:hel.12409.

    Article  Google Scholar 

  30. Thorell K, Hosseini S, Palacios Gonzales RV, Chaotham C, Graham DY, Paszat L, et al. Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua. BMC Evol Biol. 2016;16:53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, et al. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk. BMC Biol. 2018;16:84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Quintana-Hayashi MP, Rocha R, Padra M, Thorell A, Jin C, Karlsson NG, et al. BabA-mediated adherence of pediatric ulcerogenic H. pylori strains to gastric mucins at neutral and acidic pH. Virulence. 2018;9:1699–717.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Boonyanugomol W, Chomvarin C, Hahnvajanawong C, Sripa B, Kaparakis-Liaskos M, Ferrero RL. Helicobacter pylori cag pathogenicity island (cagPAI) involved in bacterial internalization and IL-8 induced responses via NOD1- and MyD88-dependent mechanisms in human biliary epithelial cells. PLoS ONE. 2013;8:e77358.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. van Vliet AH. Use of pan-genome analysis for the identification of lineage-specific genes of Helicobacter pylori. FEMS Microbiol Lett. 2017;364:fnw296.

    Article  PubMed  CAS  Google Scholar 

  35. Thorell K, Yahara K, Berthenet E, Lawson DJ, Mikhail J, Kato I, et al. Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas. PLoS Genet. 2017;13:e1006546.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Munoz-Ramirez ZY, Pascoe B, Mendez-Tenorio A, Mourkas E, Sandoval-Motta S, Perez-Perez G, et al. A 500-year tale of co-evolution, adaptation, and virulence: Helicobacter pylori in the Americas. ISME J. 2020;15:78–92.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mane SP, Dominguez-Bello MG, Blaser MJ, Sobral BW, Hontecillas R, Skoneczka J, et al. Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol. 2010;192:3078–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398–402.

    Article  CAS  PubMed  Google Scholar 

  39. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193–201.

    Article  CAS  PubMed  Google Scholar 

  40. Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43:1215–8.

    Article  CAS  PubMed  Google Scholar 

  41. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42:764–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Study Group of Millennium Genome Project for C, Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 2008;40:730–40.

    Article  CAS  Google Scholar 

  43. Song HR, Kim HN, Kweon SS, Choi JS, Shim HJ, Cho SH, et al. Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population. Mol Carcinog. 2013;52:E155–60.

    Article  CAS  PubMed  Google Scholar 

  44. Yan C, Zhu M, Ding Y, Yang M, Wang M, Li G, et al. Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations. Gut. 2020;69:641–51.

    Article  CAS  PubMed  Google Scholar 

  45. Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A, et al. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. Cancer Sci. 2018;109:4015–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, et al. Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet. 2015;47:906–10.

    Article  CAS  PubMed  Google Scholar 

  47. Sobota RS, Kodaman N, Mera R, Piazuelo MB, Bravo LE, Pazos A, et al. Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Hum Genet. 2016;135:895–906.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Alvarez MC, Fernandes J, Michel V, Touati E, Ribeiro ML. Effect of Helicobacter pylori infection on GATA-5 and TFF1 regulation, comparison between pediatric and adult patients. Dig Dis Sci. 2018;63:2889–97.

    Article  CAS  PubMed  Google Scholar 

  49. Wen XZ, Akiyama Y, Pan KF, Liu ZJ, Lu ZM, Zhou J, et al. Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas. World J Gastroenterol. 2010;16:1201–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Kienesberger S, Cox LM, Livanos A, Zhang XS, Chung J, Perez-Perez GI, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep. 2016;14:1395–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut. 2013;62:1262–9.

    Article  PubMed  Google Scholar 

  52. Gupta V, Perez-Perez GI, Dorsey G, Rosenthal PJ, Blaser MJ. The seroprevalence of Helicobacter pylori and its relationship to malaria in Ugandan children. Trans R Soc Trop Med Hyg. 2012;106:35–42.

    Article  PubMed  Google Scholar 

  53. Koshiol J, Flores R, Lam TK, Taylor PR, Weinstein SJ, Virtamo J, et al. Helicobacter pylori seropositivity and risk of lung cancer. PLoS ONE. 2012;7:e32106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.

    Article  CAS  PubMed  Google Scholar 

  55. Chen TH, Cheng HT, Yeh CT. Epidemiology changes in peptic ulcer diseases 18 years apart explored from the genetic aspects of Helicobacter pylori. Transl Res. 2020;232:115–20.

    Article  PubMed  CAS  Google Scholar 

  56. Tumgor G, Agin M, Doran F, Cetiner S. Frequency of celiac disease in children with peptic ulcers. Dig Dis Sci. 2018;63:2681–6.

    Article  PubMed  Google Scholar 

  57. Agin M, Batun I, Ozdemir S, Doran F, Tumgor G. Prevalence of Helicobacter pylori in Turkish children with celiac disease and its effect on clinical, histopathological, and laboratory parameters. Arch Med Sci. 2019;15:1475–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175–6.

    Article  CAS  PubMed  Google Scholar 

  59. Craig VJ, Arnold I, Gerke C, Huynh MQ, Wundisch T, Neubauer A, et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood. 2010;115:581–91.

    Article  CAS  PubMed  Google Scholar 

  60. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–7.

    Article  CAS  PubMed  Google Scholar 

  61. Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C. MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018;11:187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Dadashi M, Hajikhani B, Ghazi M, Yazdani S, Goudarzi M, Nasiri MJ, et al. The global prevalence of Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus and Herpes simplex virus in patients with coronary artery disease: a systematic review and meta-analysis. Microb Pathog. 2020;152:104572.

    Article  PubMed  CAS  Google Scholar 

  63. Kato S, Osaki T, Kamiya S, Zhang XS, Blaser MJ. Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence. PLoS ONE. 2017;12:e0184046.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol. 2010;26:618–23.

    Article  PubMed  Google Scholar 

  65. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med. 1994;120:977–81.

    Article  CAS  PubMed  Google Scholar 

  66. Yap TW, Leow AH, Azmi AN, Callahan DL, Perez-Perez GI, Loke MF, et al. Global fecal and plasma metabolic dynamics related to helicobacter pylori eradication. Front Microbiol. 2017;8:536.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Malnick SD, Melzer E, Attali M, Duek G, Yahav J. Helicobacter pylori: friend or foe? World J Gastroenterol. 2014;20:8979–85.

    PubMed  PubMed Central  Google Scholar 

  68. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14:26–38.

    CAS  PubMed  Google Scholar 

  69. Doulberis M, Kountouras J, Rogler G. Reconsidering the “protective” hypothesis of Helicobacter pylori infection in eosinophilic esophagitis. Ann N Y Acad Sci. 2020;1481:59–71.

    Article  PubMed  Google Scholar 

  70. Ness-Jensen E, Langhammer A, Hveem K, Lu Y. Helicobacter pylori in relation to asthma and allergy modified by abdominal obesity: the HUNT study in Norway. World Allergy Organ J. 2019;12:100035.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008;198:553–60.

    Article  PubMed  Google Scholar 

  72. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007;167:821–7.

    Article  PubMed  Google Scholar 

  73. Fouda EM, Kamel TB, Nabih ES, Abdelazem AA. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity. Allergol Immunopathol (Madr). 2018;46:76–81.

    Article  CAS  Google Scholar 

  74. Khamechian T, Movahedian AH, Ebrahimi Eskandari G, Heidarzadeh Arani M, Mohammadi A. Evaluation of the correlation between childhood asthma and Helicobacter pylori in Kashan. Jundishapur J Microbiol. 2015;8:e17842.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS ONE. 2008;3:e4060.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Annagur A, Kendirli SG, Yilmaz M, Altintas DU, Inal A. Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori. J Trop Pediatr. 2007;53:313–8.

    Article  PubMed  Google Scholar 

  77. Koch KN, Hartung ML, Urban S, Kyburz A, Bahlmann AS, Lind J, et al. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Investig. 2015;125:3297–302.

    Article  PubMed  PubMed Central  Google Scholar 

  78. den Hollander WJ, Sonnenschein-van der Voort AM, Holster IL, de Jongste JC, Jaddoe VW, Hofman A, et al. Helicobacter pylori in children with asthmatic conditions at school age, and their mothers. Aliment Pharm Ther. 2016;43:933–43.

    Article  Google Scholar 

  79. Elias N, Nasrallah E, Khoury C, Mansour B, Abu Zuher L, Asato V, et al. Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma. Pediatr Pulmonol. 2020;55:2236–45.

    Article  PubMed  Google Scholar 

  80. Tsigalou C, Konstantinidis TG, Cassimos D, Karvelas A, Grapsa A, Tsalkidis A, et al. Inverse association between Helicobacter pylori infection and childhood asthma in Greece: a case-control study. Germs. 2019;9:182–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Francois F, Roper J, Joseph N, Pei Z, Chhada A, Shak JR, et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol. 2011;11:37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Zuo ZT, Ma Y, Sun Y, Bai CQ, Ling CH, Yuan FL. The protective effects of helicobacter pylori infection on allergic asthma. Int Arch Allergy Immunol. 2021;182:53–64.

    Article  CAS  PubMed  Google Scholar 

  83. van Wijck Y, John-Schuster G, van Schadewijk A, van den Oever RL, Obieglo K, Hiemstra PS, et al. Extract of helicobacter pylori ameliorates parameters of airway inflammation and goblet cell hyperplasia following repeated allergen exposure. Int Arch Allergy Immunol. 2019;180:1–9.

    Article  PubMed  CAS  Google Scholar 

  84. Axelrad JE, Cadwell KH, Colombel JF, Shah SC. Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharm Ther. 2020;51:1222–32.

    Article  Google Scholar 

  85. Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol. 2020;33:485–94.

    PubMed  PubMed Central  Google Scholar 

  86. Rokkas T, Gisbert JP, Niv Y, O’Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United European. Gastroenterol J. 2015;3:539–50.

    CAS  Google Scholar 

  87. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077–84.

    Article  PubMed  Google Scholar 

  88. Rothenbacher D, Blaser MJ, Bode G, Brenner H. Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J Infect Dis. 2000;182:1446–9.

    Article  CAS  PubMed  Google Scholar 

  89. Bode G, Rothenbacher D, Brenner H. Helicobacter pylori colonization and diarrhoeal illness: results of a population-based cross-sectional study in adults. Eur J Epidemiol. 2001;17:823–7.

    Article  CAS  PubMed  Google Scholar 

  90. Perry S, de Jong BC, Solnick JV, de la Luz Sanchez M, Yang S, Lin PL, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS ONE. 2010;5:e8804.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, Sobota RS, et al. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci USA. 2014;111:1455–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007;445:915–8.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Kodaman N, Sobota RS, Mera R, Schneider BG, Williams SM. Disrupted human-pathogen co-evolution: a model for disease. Front Genet. 2014;5:290.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Gutierrez-Escobar AJ, Velapatino B, Borda V, Rabkin CS, Tarazona-Santos E, Cabrera L, et al. Identification of new helicobacter pylori subpopulations in Native Americans and Mestizos From Peru. Front Microbiol. 2020;11:601839.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Ansari S, Yamaoka Y. Helicobacter pylori BabA in adaptation for gastric colonization. World J Gastroenterol. 2017;23:4158–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Harrison U, Fowora MA, Seriki AT, Loell E, Mueller S, Ugo-Ijeh M, et al. Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile. PLoS ONE. 2017;12:e0176454.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Mahant S, Sharma AK, Gehlot V, Mukhopadhyay AK, Chhawchharia A, Dutta S, et al. Geographically distinct North-East Indian Helicobacter pylori strains are highly sensitive to clarithromycin but are levofloxacin resistant. Indian J Med Microbiol. 2019;37:337–44.

    Article  PubMed  Google Scholar 

  98. Alarcon-Millan J, Fernandez-Tilapa G, Cortes-Malagon EM, Castanon-Sanchez CA, De Sampedro-Reyes J, Cruz-Del, et al. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern Mexico with chronic gastritis. Infect Genet Evol. 2016;44:190–8.

    Article  CAS  PubMed  Google Scholar 

  99. Miller AK, Tavera G, Dominguez R, Camargo MC, Waterboer T, Wilson KT, et al. Ornithine Decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus. medRxiv. 2021: https://doi.org/10.1101/2021.04.13.21254467.

  100. Zell JA, McLaren CE, Chen WP, Thompson PA, Gerner EW, Meyskens FL. Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst. 2010;102:1513–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Sierra MS, Cueva P, Bravo LE, Forman D. Stomach cancer burden in Central and South America. Cancer Epidemiol. 2016;44:S62–S73.

    Article  PubMed  Google Scholar 

  102. Corral JE, Delgado Hurtado JJ, Dominguez RL, Valdez de Cuellar M, Balmore Cruz C, Morgan DR. The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations. J Gastrointest Cancer. 2015;46:21–8.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R et al. editors. Cancer Incidence in Five Continents. Vol XI (electronic version) Lyon: International Agency for Research on Cancer. Available from https://ci5iarcfr, accessed 01/15/2021. 2017.

  104. Roussos A, Philippou N, Mantzaris GJ, Gourgoulianis KI. Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration 2006;73:708–14.

    Article  PubMed  Google Scholar 

  105. Rozankovic PB, Huzjan AL, Cupic H, Bencic IJ, Basic S, Demarin V. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol. 2011;258:753–61.

    Article  PubMed  Google Scholar 

  106. Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vasc Health Risk Manag. 2012;6:455–61.

    Article  PubMed  CAS  Google Scholar 

  107. den Hollander WJ, Schalekamp-Timmermans S, Holster IL, Jaddoe VW, Hofman A, Moll HA, et al. Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth. Helicobacter. 2017;22:hel.12364.

    Article  CAS  Google Scholar 

  108. Xia B, Wang W, Lu Y, Chen C. Helicobacter pylori infection increases the risk of metabolic syndrome in pregnancy: a cohort study. Ann Transl Med. 2020;8:875.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  109. Lebwohl B, Blaser MJ, Ludvigsson JF, Green PH, Rundle A, Sonnenberg A, et al. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol. 2013;178:1721–30.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid diseases and Helicobacter pylori: the correlation is present only in Graves’s disease. World J Gastroenterol. 2012;18:1093–7.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis. 2012;205:1195–202.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott M. Williams.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, A.K., Williams, S.M. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes Immun 22, 218–226 (2021). https://doi.org/10.1038/s41435-021-00146-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41435-021-00146-4

This article is cited by

Search

Quick links